Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Gaudet, Laura M ^a,b,c   Singh, Kavita ^a   Weeks, Laura ^a   Skidmore, Becky ^a   Tsertsvadze, Alexander ^a   Ansari, Mohammed T ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MONCTON HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; PLACEBO; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; CINAHL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PREMATURE LABOR; REPRODUCIBILITY; RISK ASSESSMENT; SYSTEMATIC REVIEW; TOCOLYSIS; VALIDITY; BIRTH WEIGHT; DELIVERY; DRUG EFFECT; INFUSION PUMP; NEWBORN; PREGNANCY; PREMATURITY; PUBLISHING; REVIEW; TREATMENT OUTCOME;

ADULT; BIRTH WEIGHT; DELIVERY, OBSTETRIC; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFUSION PUMPS; PREGNANCY; PREMATURE BIRTH; PUBLICATION BIAS; TERBUTALINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857389235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031679     Document Type: Article

References (26)

1. Behrman R, Butler A, (2007) Preterm Birth: Causes, Consequences, and Prevention Washington (DC) National Academies Press.
2. Iams J, Romero R, Creasy R, (2010) Preterm labor and birth. In: Creasy R, Resnik R, Iams J, editors. Creasy and Resnik's Maternal-fetal medicine: principles and practice Philadelphia PA Saunders Elsevier pp. 545-582.
3. Nanda K, Cook LA, Gallo MF, Grimes DA, (2002) Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev.
4. Hayes Inc (2006) Continuous subcutaneous terbutaline infusion for treatment of preterm labor (Structured abstract). Health Technology Assessment Database John Wiley & Sons, Ltd.
5. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, et al. (2010) AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions-agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol 63: 513-523.
6. Atkins D, Chang S, Gartlehner G, Buckley DI, Whitlock EP, et al. (2011) Assessing applicability when comparing medical interventions: Agency for Healthcare Research and Quality and the Effective Health Care Program. J Clin Epidemiol.
7. Norris SL, Atkins D, Bruening W, Fox S, Johnson E, et al. (2011) Observational studies should be considered for inclusion in reviews of comparative effectiveness. J Clin Epidemiol.
8. Chou R, Aronson N, Atkins D, Ismaila AS, Santaguida P, et al. (2010) AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol 63: 502-512.
9. Relevo R, Balshem H, (2011) Finding evidence for comparing medical interventions: Agency for Healthcare Research and Quality (AHRQ) and the Effective Health Care program.[Epub ahead of print]. J Clin Epidemiol.
10. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
11. Allbert JR, Johnson C, Roberts WE, Martin RW, Gookin KS, et al. (1994) Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med 39: 614-618.
12. Allbert J, Johnson C, Roberts W, (1991) Subcutaneous terbutaline tocolysis for recurrent preterm labor via infusion pump. Am J Obstet Gynecol 164: 365.
13. Morrison JC, Chauhan SP, Carroll CS Sr, Bofill JA, Magann EF, (2003) Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor. Am J Obstet Gynecol 188: 1460-1465.
14. Morrison JC, Allbert JR, Floyd RC, Bale CS, Lou CH, et al. (1992) Interval to delivery in high-risk patients: Do tocolytic agents really work? Int J Gynaecol Obstet 38: 189-193.
15. Flick AA, de la Torre L, Roca LE, Istwan N, Rhea D, et al. (2010) An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor. Am J Perinatol 27: 53-59.
16. de la Torre L, Istwan NB, Desch C, Rhea DJ, Roca L, et al. (2008) Management of recurrent preterm labor in twin gestations with nifedipine tocolysis. Am J Perinatol 25: 555-560.
17. Fleming A, Bonebrake R, Istwan N, Rhea D, Coleman S, et al. (2004) Pregnancy and economic outcomes in patients treated for recurrent preterm labor. J Perinatol 24: 223-227.
18. Lam F, Istwan NB, Jacques D, Coleman SK, Stanziano GJ, (2003) Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Managed Care 12: 39-46.
19. Lam F, Bergauer NK, Jacques D, Coleman SK, Stanziano GJ, (2001) Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J Perinatol 21: 444-450.
20. Lam F, Gill P, Smith M, Kitzmiller JL, Katz M, (1988) Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 72: 810-813.
21. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC, (1998) Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial.[see comment]. Am J Obstet Gynecol 179: 874-878.
22. Lindenbaum C, Ludmir J, Teplick FB, Cohen AW, Samuels P, (1992) Maternal glucose intolerance and the subcutaneous terbutaline pump. Am J Obstet Gynecol 166: 925-928.
23. Adkins RT, Van Hooydonk JE, Bressman PL, Growdon JH Jr, Bolen PR, et al. (1993) Prevention of preterm birth: early detection and aggressive treatment with terbutaline.[see comment]. South Med J 86: 157-164.
24. Wenstrom KD, Weiner CP, Merrill D, Niebyl J, (1997) A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol 14: 87-91.
25. Regenstein AC, Belluomini J, Katz M, (1993) Terbutaline tocolysis and glucose intolerance. Obstet Gynecol 81: 739-741.
26. King JF, Grant A, Keirse MJ, Chalmers I, (1988) Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 95: 211-222.